Simponi Aria, also known by its drug name golimumab, is a biologic disease-modifying antirheumatic drug (DMARD) approved for treating adults and children over age 2 with active psoriatic arthritis. Here are some key points about Simponi Aria:
- **Administration**: It is administered as an intravenous infusion every eight Show Full Answer
Simponi Aria, also known by its drug name golimumab, is a biologic disease-modifying antirheumatic drug (DMARD) approved for treating adults and children over age 2 with active psoriatic arthritis. Here are some key points about Simponi Aria:
- **Administration**: It is administered as an intravenous infusion every eight weeks following initial loading doses.
- **Mechanism**: Simponi Aria works by inhibiting tumor necrosis factor alpha (TNF-α), which plays a role in autoimmune attacks.
- **Side Effects**: Common side effects include upper respiratory tract infections, increased liver enzymes, and hypertension. There are also rare but serious risks like severe infections and increased risk for lymphoma.
- **Packaging**: It comes in a single-dose vial.
If you're considering this treatment, it's crucial to discuss it with your healthcare provider to understand how it fits into your overall treatment plan and to consider any potential risks and benefits.
April 23, 2024
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
